Gilead Sciences Announced Definitive Agreement To Acquire Arcellx For $115 Per Share In Cash And $5 Per Share Contingent Value Right

Arcellx, Inc. +0.05%
Gilead Sciences, Inc. -2.08%

Arcellx, Inc.

ACLX

114.36

+0.05%

Gilead Sciences, Inc.

GILD

145.14

-2.08%

Gilead Sciences Announced Definitive Agreement To Acquire Arcellx For $115 Per Share In Cash And $5 Per Share Contingent Value Right
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via